Cargando…
Innovative Strategies in Tendon Tissue Engineering
The tendon is a highly aligned connective tissue that transmits force from muscle to bone. Each year, more than 32 million tendon injuries have been reported, in fact, tendinopathies represent at least 50% of all sports injuries, and their incidence rates have increased in recent decades due to the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827834/ https://www.ncbi.nlm.nih.gov/pubmed/33440840 http://dx.doi.org/10.3390/pharmaceutics13010089 |
_version_ | 1783640863810781184 |
---|---|
author | Bianchi, Eleonora Ruggeri, Marco Rossi, Silvia Vigani, Barbara Miele, Dalila Bonferoni, Maria Cristina Sandri, Giuseppina Ferrari, Franca |
author_facet | Bianchi, Eleonora Ruggeri, Marco Rossi, Silvia Vigani, Barbara Miele, Dalila Bonferoni, Maria Cristina Sandri, Giuseppina Ferrari, Franca |
author_sort | Bianchi, Eleonora |
collection | PubMed |
description | The tendon is a highly aligned connective tissue that transmits force from muscle to bone. Each year, more than 32 million tendon injuries have been reported, in fact, tendinopathies represent at least 50% of all sports injuries, and their incidence rates have increased in recent decades due to the aging population. Current clinical grafts used in tendon treatment are subject to several restrictions and there is a significant demand for alternative engineered tissue. For this reason, innovative strategies need to be explored. Tendon replacement and regeneration are complex since scaffolds need to guarantee an adequate hierarchical structured morphology and mechanical properties to stand the load. Moreover, to guide cell proliferation and growth, scaffolds should provide a fibrous network that mimics the collagen arrangement of the extracellular matrix in the tendons. This review focuses on tendon repair and regeneration. Particular attention has been devoted to the innovative approaches in tissue engineering. Advanced manufacturing techniques, such as electrospinning, soft lithography, and three-dimensional (3D) printing, have been described. Furthermore, biological augmentation has been considered, as an emerging strategy with great therapeutic potential. |
format | Online Article Text |
id | pubmed-7827834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78278342021-01-25 Innovative Strategies in Tendon Tissue Engineering Bianchi, Eleonora Ruggeri, Marco Rossi, Silvia Vigani, Barbara Miele, Dalila Bonferoni, Maria Cristina Sandri, Giuseppina Ferrari, Franca Pharmaceutics Review The tendon is a highly aligned connective tissue that transmits force from muscle to bone. Each year, more than 32 million tendon injuries have been reported, in fact, tendinopathies represent at least 50% of all sports injuries, and their incidence rates have increased in recent decades due to the aging population. Current clinical grafts used in tendon treatment are subject to several restrictions and there is a significant demand for alternative engineered tissue. For this reason, innovative strategies need to be explored. Tendon replacement and regeneration are complex since scaffolds need to guarantee an adequate hierarchical structured morphology and mechanical properties to stand the load. Moreover, to guide cell proliferation and growth, scaffolds should provide a fibrous network that mimics the collagen arrangement of the extracellular matrix in the tendons. This review focuses on tendon repair and regeneration. Particular attention has been devoted to the innovative approaches in tissue engineering. Advanced manufacturing techniques, such as electrospinning, soft lithography, and three-dimensional (3D) printing, have been described. Furthermore, biological augmentation has been considered, as an emerging strategy with great therapeutic potential. MDPI 2021-01-11 /pmc/articles/PMC7827834/ /pubmed/33440840 http://dx.doi.org/10.3390/pharmaceutics13010089 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Bianchi, Eleonora Ruggeri, Marco Rossi, Silvia Vigani, Barbara Miele, Dalila Bonferoni, Maria Cristina Sandri, Giuseppina Ferrari, Franca Innovative Strategies in Tendon Tissue Engineering |
title | Innovative Strategies in Tendon Tissue Engineering |
title_full | Innovative Strategies in Tendon Tissue Engineering |
title_fullStr | Innovative Strategies in Tendon Tissue Engineering |
title_full_unstemmed | Innovative Strategies in Tendon Tissue Engineering |
title_short | Innovative Strategies in Tendon Tissue Engineering |
title_sort | innovative strategies in tendon tissue engineering |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827834/ https://www.ncbi.nlm.nih.gov/pubmed/33440840 http://dx.doi.org/10.3390/pharmaceutics13010089 |
work_keys_str_mv | AT bianchieleonora innovativestrategiesintendontissueengineering AT ruggerimarco innovativestrategiesintendontissueengineering AT rossisilvia innovativestrategiesintendontissueengineering AT viganibarbara innovativestrategiesintendontissueengineering AT mieledalila innovativestrategiesintendontissueengineering AT bonferonimariacristina innovativestrategiesintendontissueengineering AT sandrigiuseppina innovativestrategiesintendontissueengineering AT ferrarifranca innovativestrategiesintendontissueengineering |